• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺乏全局 Stap1 表达的小鼠不会表现出高胆固醇血症。

Mice lacking global Stap1 expression do not manifest hypercholesterolemia.

机构信息

Division of Endocrinology, Diabetes and Metabolism, University of Cincinnati, Cincinnati, OH, USA.

Department of Pathology, University of Cincinnati, Cincinnati, OH, USA.

出版信息

BMC Med Genet. 2020 Nov 23;21(1):234. doi: 10.1186/s12881-020-01176-x.

DOI:10.1186/s12881-020-01176-x
PMID:33228548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7685646/
Abstract

BACKGROUND

Autosomal dominant familial hypercholesterolemia (ADH; MIM#143890) is one of the most common monogenic disorders characterized by elevated circulatory LDL cholesterol. Initial studies in humans with ADH identified a potential relationship with variants of the gene encoding signal transducing adaptor family member protein 1 (STAP1; MIM#604298). However, subsequent studies have been contradictory. In this study, mice lacking global Stap1 expression (Stap1) were characterized under standard chow and a 42% kcal western diet (WD).

METHODS

Mice were studied for changes in different metabolic parameters before and after a 16-week WD regime. Growth curves, body fats, circulatory lipids, parameters of glucose homeostasis, and liver architecture were studied for comparisons.

RESULTS

Surprisingly, Stap1 mice fed the 16-week WD demonstrated no marked differences in any of the metabolic parameters compared to Stap1 mice. Furthermore, hepatic architecture and cholesterol content in FPLC-isolated lipoprotein fractions also remained comparable to wild-type mice.

CONCLUSION

These results strongly suggest that STAP1 does not alter lipid levels, that a western diet did not exacerbate a lipid disorder in Stap1 deficient mice and support the contention that it is not causative for hyperlipidemia in ADH patients. These results support other published studies also questioning the role of this locus in human hypercholesterolemia.

摘要

背景

常染色体显性家族性高胆固醇血症(ADH;MIM#143890)是最常见的单基因疾病之一,其特征为循环 LDL 胆固醇升高。最初对 ADH 患者的研究发现,信号转导衔接子家族成员蛋白 1(STAP1;MIM#604298)基因编码变体与该疾病之间可能存在关联。然而,随后的研究结果却相互矛盾。在这项研究中,研究人员对缺乏全局 Stap1 表达(Stap1)的小鼠在标准饲料和 42%热量西方饮食(WD)下的特征进行了研究。

方法

在进行为期 16 周的 WD 饮食方案之前和之后,对小鼠的不同代谢参数变化进行了研究。对生长曲线、体脂肪、循环脂质、葡萄糖稳态参数和肝脏结构进行了研究,以进行比较。

结果

令人惊讶的是,与 Stap1 小鼠相比,喂食 16 周 WD 的 Stap1 小鼠在任何代谢参数上均无明显差异。此外,FPLC 分离的脂蛋白部分的肝结构和胆固醇含量也与野生型小鼠相当。

结论

这些结果强烈表明 STAP1 不会改变脂质水平,WD 饮食不会使 Stap1 缺乏的小鼠脂质代谢紊乱恶化,并支持 STAP1 基因不是 ADH 患者发生高脂血症的原因的观点。这些结果支持了其他质疑该基因座在人类高胆固醇血症中作用的已发表研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3c8/7685646/1d4ec53705d7/12881_2020_1176_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3c8/7685646/7458eaa1905c/12881_2020_1176_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3c8/7685646/176bcd3a7b00/12881_2020_1176_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3c8/7685646/c7713e670205/12881_2020_1176_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3c8/7685646/20aba57c825e/12881_2020_1176_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3c8/7685646/1d4ec53705d7/12881_2020_1176_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3c8/7685646/7458eaa1905c/12881_2020_1176_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3c8/7685646/176bcd3a7b00/12881_2020_1176_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3c8/7685646/c7713e670205/12881_2020_1176_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3c8/7685646/20aba57c825e/12881_2020_1176_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3c8/7685646/1d4ec53705d7/12881_2020_1176_Fig5_HTML.jpg

相似文献

1
Mice lacking global Stap1 expression do not manifest hypercholesterolemia.缺乏全局 Stap1 表达的小鼠不会表现出高胆固醇血症。
BMC Med Genet. 2020 Nov 23;21(1):234. doi: 10.1186/s12881-020-01176-x.
2
Taking One Step Back in Familial Hypercholesterolemia: Does Not Alter Plasma LDL (Low-Density Lipoprotein) Cholesterol in Mice and Humans.家族性高胆固醇血症中的退一步:不会改变小鼠和人类血浆 LDL(低密度脂蛋白)胆固醇。
Arterioscler Thromb Vasc Biol. 2020 Apr;40(4):973-985. doi: 10.1161/ATVBAHA.119.313470. Epub 2020 Jan 30.
3
Mutations in STAP1 are associated with autosomal dominant hypercholesterolemia.STAP1 基因突变与常染色体显性遗传性高胆固醇血症有关。
Circ Res. 2014 Aug 29;115(6):552-5. doi: 10.1161/CIRCRESAHA.115.304660. Epub 2014 Jul 17.
4
Predicted pathogenic mutations in STAP1 are not associated with clinically defined familial hypercholesterolemia.STAP1 中预测的致病性突变与临床定义的家族性高胆固醇血症无关。
Atherosclerosis. 2020 Jan;292:143-151. doi: 10.1016/j.atherosclerosis.2019.11.025. Epub 2019 Nov 29.
5
Failure of cosegregation between a rare STAP1 missense variant and hypercholesterolemia.一种罕见的 STAP1 错义变异与高胆固醇血症之间的共分离失败。
J Clin Lipidol. 2020 Sep-Oct;14(5):636-638. doi: 10.1016/j.jacl.2020.07.010. Epub 2020 Jul 24.
6
A rare STAP1 mutation incompletely associated with familial hypercholesterolemia.一种罕见的与家族性高胆固醇血症不完全相关的 STAP1 突变。
Clin Chim Acta. 2018 Dec;487:270-274. doi: 10.1016/j.cca.2018.10.014. Epub 2018 Oct 9.
7
Evaluation of the role of STAP1 in Familial Hypercholesterolemia.评价 STAP1 在家族性高胆固醇血症中的作用。
Sci Rep. 2019 Aug 19;9(1):11995. doi: 10.1038/s41598-019-48402-y.
8
FH4=STAP1. Another gene for familial hypercholesterolemia? Relevance to cascade testing and drug development?四氢叶酸=信号转导衔接蛋白1。家族性高胆固醇血症的另一个基因?与串联检测及药物研发的相关性?
Circ Res. 2014 Aug 29;115(6):534-6. doi: 10.1161/CIRCRESAHA.114.304801.
9
Delisting : The Rise and Fall of a Putative Hypercholesterolemia Gene.除名:一个假定的高胆固醇血症基因的兴衰
Arterioscler Thromb Vasc Biol. 2020 Apr;40(4):847-849. doi: 10.1161/ATVBAHA.120.314006. Epub 2020 Mar 25.
10
Disruption of autosomal recessive hypercholesterolemia gene shows different phenotype in vitro and in vivo.常染色体隐性高胆固醇血症基因的破坏在体外和体内表现出不同的表型。
Circ Res. 2004 Oct 29;95(9):945-52. doi: 10.1161/01.RES.0000146946.78540.46. Epub 2004 Oct 7.

引用本文的文献

1
Evaluation of a novel rapid genomic test including polygenic risk scores for the diagnosis and management of familial hypercholesterolaemia.一种新型快速基因组检测方法的评估,该方法包括用于家族性高胆固醇血症诊断和管理的多基因风险评分。
Glob Cardiol Sci Pract. 2021 Dec 31;2021(4):e202131. doi: 10.21542/gcsp.2021.31.
2
The Importance of Arterial Stiffness Assessment in Patients with Familial Hypercholesterolemia.家族性高胆固醇血症患者动脉僵硬度评估的重要性
J Clin Med. 2022 May 19;11(10):2872. doi: 10.3390/jcm11102872.

本文引用的文献

1
Taking One Step Back in Familial Hypercholesterolemia: Does Not Alter Plasma LDL (Low-Density Lipoprotein) Cholesterol in Mice and Humans.家族性高胆固醇血症中的退一步:不会改变小鼠和人类血浆 LDL(低密度脂蛋白)胆固醇。
Arterioscler Thromb Vasc Biol. 2020 Apr;40(4):973-985. doi: 10.1161/ATVBAHA.119.313470. Epub 2020 Jan 30.
2
Dopamine Signaling in the Suprachiasmatic Nucleus Enables Weight Gain Associated with Hedonic Feeding.视交叉上核中的多巴胺信号使与享乐性进食相关的体重增加成为可能。
Curr Biol. 2020 Jan 20;30(2):196-208.e8. doi: 10.1016/j.cub.2019.11.029. Epub 2020 Jan 2.
3
Familial hypercholesterolemia: A complex genetic disease with variable phenotypes.
家族性高胆固醇血症:一种具有可变表型的复杂遗传性疾病。
Eur J Med Genet. 2020 Apr;63(4):103831. doi: 10.1016/j.ejmg.2019.103831. Epub 2019 Dec 25.
4
Predicted pathogenic mutations in STAP1 are not associated with clinically defined familial hypercholesterolemia.STAP1 中预测的致病性突变与临床定义的家族性高胆固醇血症无关。
Atherosclerosis. 2020 Jan;292:143-151. doi: 10.1016/j.atherosclerosis.2019.11.025. Epub 2019 Nov 29.
5
Genes Potentially Associated with Familial Hypercholesterolemia.与家族性高胆固醇血症相关的基因。
Biomolecules. 2019 Nov 29;9(12):807. doi: 10.3390/biom9120807.
6
TFEB drives PGC-1α expression in adipocytes to protect against diet-induced metabolic dysfunction.TFEB 驱动脂肪细胞中 PGC-1α 的表达,以防止饮食引起的代谢功能障碍。
Sci Signal. 2019 Nov 5;12(606):eaau2281. doi: 10.1126/scisignal.aau2281.
7
The atherogenic role of immune cells in familial hypercholesterolemia.免疫细胞在家族性高胆固醇血症中的致动脉粥样硬化作用。
IUBMB Life. 2020 Apr;72(4):782-789. doi: 10.1002/iub.2179. Epub 2019 Oct 21.
8
Evaluation of the role of STAP1 in Familial Hypercholesterolemia.评价 STAP1 在家族性高胆固醇血症中的作用。
Sci Rep. 2019 Aug 19;9(1):11995. doi: 10.1038/s41598-019-48402-y.
9
The island of Gran Canaria: A genetic isolate for familial hypercholesterolemia.大加那利岛:家族性高胆固醇血症的遗传隔离岛。
J Clin Lipidol. 2019 Jul-Aug;13(4):618-626. doi: 10.1016/j.jacl.2019.04.099. Epub 2019 May 8.
10
Application of expanded genetic analysis in the diagnosis of familial hypercholesterolemia in patients with very early-onset coronary artery disease.扩展基因分析在极早发冠心病家族性高胆固醇血症患者中的应用。
J Transl Med. 2018 Dec 10;16(1):345. doi: 10.1186/s12967-018-1737-7.